InMed Pharmaceuticals files PCT patent application for the treatment of pain with Cannabinoids
Tuesday, September 25, 2018 DrugName : INM-405 InMed Pharmaceuticals Inc., a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary
Read More